RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
ANNALS OF THE RHEUMATIC DISEASES
Collezione ASL Città di Torino

Items : 3

2023 ACR/EULAR antiphospholipid syndrome classification criteria. in Annals of the rheumatic diseases / Ann Rheum Dis. 2023 Oct;82(10):1258-1270. doi: 10.1136/ard-2023-224609. Epub 2023 Aug 28.

2023
ASL Città di Torino

Barbhaiya M; Zuily S; Naden R; Hendry A; Manneville F; Amigo MC; Amoura Z; Andrade D; Andreoli L; Artim-Esen B; Atsumi T; Avcin T; Belmont HM; Bertolaccini ML; Branch DW; Carvalheiras G; Casini A; Cervera R; Cohen H; Costedoat-Chalumeau N; Crowther M; de Jesús G; Delluc A; Desai S; Sancho M; Devreese KM; Diz-Kucukkaya R; Duarte-García A; Frances C; et alii...

Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination. in Annals of the rheumatic diseases / Ann Rheum Dis. 2022 Sep 12;81(10):1476-1477. doi: 10.1136/ard-2022-222832.

2022
ASL Città di Torino

Ramirez GA; Argolini LM; Schioppo T; Sciascia S; Moroni L; Moroni G; Sinico RA; Bonelli G; Alberici F; Mescia F; Tamborini F; Miraglia P; Bellocchi C; Beretta L; Roccatello D; Bozzolo EP; Caporali R; Gerosa M; Dagna L;

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. in Annals of the rheumatic diseases / Ann Rheum Dis. 2022 Jun;81(6):768-779. doi: 10.1136/annrheumdis-2021-221733. Epub 2022 Feb 2.

2022
ASL Città di Torino

Drosos GC; Vedder D; Houben E; Boekel L; Atzeni F; Badreh S; Boumpas DT; Brodin N; Bruce IN; González-Gay MÁ; Jacobsen S; Kerekes G; Marchiori F; Mukhtyar C; Ramos-Casals M; Sattar N; Schreiber K; Sciascia S; Svenungsson E; Szekanecz Z; Tausche AK; Tyndall A; van Halm V; Voskuyl A; Macfarlane GJ; Ward MM; Nurmohamed MT; Tektonidou MG;